Injectable Drug Delivery Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Device Type (Needle-free Injectors, Patch Injectors, Auto Injectors, Others), By Application (Disease Treatment, Research/Academic Purposes), And By Geography - Forecasts From 2019 To 2024
- Published : May 2020
- Report Code : KSI061612654
- Pages : 118
Offered with this report
Market Data and Estimates in Excel
2 Months of Post Sale Analyst Support
Requirement Specific Customization
The injectable drug delivery market is projected to grow at a CAGR of 10.37% to reach US$ 804.844 billion by 2024. Injectable drug delivery is considered to be the most effective means of drug delivery into the human body and is thus considered to be the most effective administration route. These are in high demand due to the prevalence of chronic diseases worldwide driving the market growth during the forecast period. Furthermore, growing R&D activities, growing health expenditure and growing age-related diseases with the increasing elderly population worldwide are also driving the growth of the global injectable drug delivery market in the forecast period.
DRIVERS
Prevalence of chronic diseases worldwide.
Increasing health expenditure worldwide.
Growing geriatric population.
RESTRAINTS
Stringent regulations regarding approval of drugs and medical devices.
INDUSTRY UPDATE
On May 2, 2018, Haselmeier which is a Swiss-based developer and manufacturer of innovative self-injection devices announced that it has entered into a partnership agreement with the Common sensing which is a Cambridge-based smart injector monitoring and support solutions company. The partnership is for the development of smart connected monitoring and support solutions for the patients using injectable medicines.
On July 26, 2018, Merck and InnoCore Pharmaceuticals entered into a global cooperation agreement for providing InnoCore’s proprietary SynBiosys® biodegradable polymer platform, this further can be used for the development of sustained release solutions for biologicals in injectable formulations.
The major players profiled in the injectable drug delivery market include Wilhelm Haselmeier GmbH & Co. KG, Owen Mumford Ltd., SHL Medical AG, Enable Injections, and Ypsomed AG.
Injectable Drug Delivery Market Scope:
| Report Metric | Details |
| Market size value in 2024 | US$804.844 billion |
| Growth Rate | CAGR of 10.37% from 2018 to 2024 |
| Base year | 2018 |
| Forecast period | 2019–2024 |
| Forecast Unit (Value) | USD Billion |
| Segments covered | Device Type, Application, And Geography |
| Regions covered | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Companies covered | Wilhelm Haselmeier GmbH & Co. KG, Owen Mumford Ltd., SHL Medical AG, Enable Injections, Ypsomed AG |
| Customization scope | Free report customization with purchase |
Segmentation
The injectable drug delivery market has been analyzed through the following segments:
By Device Type
Needle-free injectors
Patch injectors
Auto injectors
Others
By Application
Disease Treatment
Research/Academic purposes
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
Frequently Asked Questions (FAQs)
Q1. What are the growth prospects for injectable drug delivery market?
A1. The injectable drug delivery market is projected to grow at a CAGR of 10.37% during the forecast period.
Q2. What will be the injectable drug delivery market size by 2024?
A2. The global injectable drug delivery market is projected to reach a total market size of US$804.844 billion by 2024.
Q3. Who are the major players in the injectable drug delivery market?
A3. The major players profiled in the injectable drug delivery market include Wilhelm Haselmeier GmbH & Co. KG, Owen Mumford Ltd., SHL Medical AG, Enable Injections, and Ypsomed AG.
Q4. What factors are anticipated to drive the injectable drug delivery market growth?
A4. Due to the prevalence of chronic diseases worldwide driving injectable drug delivery market growth during the forecast period.
Q5. How is the global injectable drug delivery market segmented?
A5. The injectable drug delivery market has been segmented by device type, application, and geography.
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. INJECTABLE DRUG DELIVERY MARKET BY DEVICE TYPE
5.1. Needle-free injectors
5.2. Patch injectors
5.3. Auto injectors
5.4. Others
6. INJECTABLE DRUG DELIVERY MARKET BY APPLICATION
6.1. Disease Treatment
6.2. Research/Academic purposes
7. INJECTABLE DRUG DELIVERY MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. UAE
7.4.3. Israel
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. India
7.5.3. Australia
7.5.4. South Korea
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Company Benchmarking and Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Wilhelm Haselmeier GmbH & Co. KG
9.2. Owen Mumford Ltd.
9.3. SHL Medical AG
9.4. Enable Injections
9.5. Ypsomed AG
LIST OF FIGURES
LIST OF TABLES
Wilhelm Haselmeier GmbH & Co. KG
Owen Mumford Ltd.
SHL Medical AG
Enable Injections
Ypsomed AG
Related Reports
| Report Name | Published Month | Get Sample PDF |
|---|---|---|
| Drug Delivery Market Size & Share: Industry Report, 2024-2029 | Apr 2024 | |
| Drug Delivery Polymer Market Size & Share: Report, 2023-2028 | Sep 2023 | |
| China Drug Delivery Market Size & Share: Report, 2024-2029 | Feb 2024 | |
| North America Drug Delivery Market Size: Report, 2023 - 2028 | Dec 2023 | |
| Mexico Drug Delivery Market Size: Industry Report, 2022-2027 | May 2022 |